[癌登第107004號通知文] 因應107年癌症登記實務作業之需求，請 貴院依說明段辦理

一、本案係依衛生福利部國民健康署委託「台灣癌症登記工作計畫」辦理。

二、依據本中心諮詢專家意見以及參考SEER Inquiry System，有部分需修正的編碼或不需申報的個案，說明如下：

(1) 修正原8311/3 Succinate dehydrogenase-deficient renal carcinoma (C64.9)，應編碼為8312/3較為適宜。(請見全文下載附件一)

Question：

What is the correct ICD-O-3 histology code for Succinate dehydrogenase-deficient renal carcinoma of kidney?

Answer：

Per WHO 4th Ed Urinary Tumors, Succinate dehydrogenase-deficient renal carcinoma of kidney is extremely rare. A specific ICD-O code has not been assigned to this histology. Code the case to renal cell carcinoma, NOS (8312/3).

(2) Low-grade appendiceal mucinous neoplasm (LAMN) (C18.1) 個案不需申報至癌登中心。

Question 20180032：

Is low-grade appendiceal mucinous neoplasm (LAMN) reportable for 2018? It is staged as pTis(LAMN) AJCC 8th ed by pathologist.

Answer：

Low-grade appendiceal mucinous neoplasm (LAMN) is not reportable in 2018. See page 6, https://20tqtx36s1la18rvn82wcmpn-wpengine.netdna-ssl.com/wp-content/uploads/2018/02/2018-ICD-O-3-Coding-Table-Alpha-order-.pdf. Use cancer registry reportability instructions to determine reportability. Do not use the AJCC TNM manual to determine reportability.

三、依據癌登第107003號通知文有關2017年WHO出版血液腫瘤藍皮書內容，為能落實癌症登記資料收錄之正確性與完整性，中華民國血液病學會已協助增修「血液腫瘤診斷檢核表」(請見全文下載附件二)，以提供所有癌登醫院使用。

[癌登第107004號通知文全文下載]